Media Coverage Archives - Castle Creek Biosciences, Inc. : Castle Creek Biosciences, Inc.

November 11, 2020

1st Patient Treated in Phase 3 Trial of RDEB Gene Therapy, D-Fi

October 29, 2020

Castle Creek Biosciences’ D-Fi To Be Manufactured At In-House cGMP

October 20, 2020

First Patient Treated in Trial Testing FCX-013 Gene Therapy for Localized Scleroderma

May 09, 2020

9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation

January 02, 2020

“Acquisition Combines Two Pipelines for Rare Skin Diseases” John Maslowski, CEO, Castle Creek Biosciences

Media Coverage